Evidence map›Paper›PMID 32027044›Full record

ArticleJPEN. Journal of parenteral and enteral nutrition2020

Targeted Approaches for In Situ Gut Microbiome Manipulation.

Gail A M Cresci, Johanna W Lampe, Glenn Gibson

Abstract read
In one paragraph

Article in JPEN. Journal of parenteral and enteral nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. The Use of CRISPR/Cas9 as a Tool to Study Human Infectious Viruses.Frontiers in cellular and infection microbiology · 2021
    Review
  7. The gut-liver axis as a target of liver disease management.Hepatobiliary surgery and nutrition · 2021
    Article
  8. Microbiota reprogramming for treatment of alcohol-related liver disease.Translational research : the journal of laboratory and clinical medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gail A M CresciDepartment of Pediatric Gastroenterology, Cleveland Clinic Children's Hospital, Cleveland, Ohio, USA.ORCID 0000-0002-5717-7099
Johanna W LampeFred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Glenn GibsonDepartment of Food and Nutritional Sciences, The University of Reading, Reading, UK.

Funding

Gut Microbiota and colonic gene expression: A ligran trial in humansU01CA162077 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CHAPKIN, ROBERT STEPHEN, HULLAR, MEREDITH · 2011 to 2015
$3.2M
Human and Bacterial Molecular Pathways in Cancer Risk: Modulation by DietR01CA192222 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LAMPE, JOHANNA W · 2016 to 2019
$2.9M
Targeting ethanol-induced gut dysbiosis with synbiotics to treat alcoholic liverR00AA023266 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI CRESCI, GAIL ANN · 2017 to 2019
$747k
NCI NIH HHS U01 CA162077NIAAA NIH HHS 4R00AA023266NIAAA NIH HHS R00 AA023266NIH HHS R01 CA192222NIH HHS U01 CA162077
6 · The paper itself

Abstract

The 2019 Dudrick Research Symposium, entitled "Targeted Approaches for In Situ Gut Microbiome Manipulation," was held on March 25, 2019, at the American Society for Parenteral and Enteral Nutrition (ASPEN) 2019 Nutrition Science & Practice Conference in Phoenix, AZ. The Dudrick Symposium honors the many pivotal and innovative contributions to the development and advancement of parenteral nutrition (PN) made by Dr Stanley J. Dudrick, physician scientist, academic leader, and a founding member of ASPEN. As the 2018 recipient of the Dudrick award, Dr Gail Cresci organized and chaired the symposium. The symposium addressed the evolving field of nutrition manipulation of the gut microbiome as a means to mitigate disease and support health. Presentations focused on (1) the role of prebiotics as a means to beneficially support gut microbiome composition and function and health; (2) designer synbiotics targeted to support metabolic by-products altered by ethanol exposure and microbial effectors that manipulate host metabolic outcomes; and, lastly, (3) types of intervention designs used to study diet-gut microbiome interactions in humans and a review of findings from recent interventions, which tested the effects of diet on the microbiome and the microbiome's effect on dietary exposures. New molecular techniques and multiomic approaches have improved knowledge of the structure and functional activity of the gut microbiome; however, challenges remain in establishing causal relationships between changes in the gut microbial-community structure and function and health outcomes in humans.

Indexed as

Gastrointestinal MicrobiomeDietHumansNutritional StatusPrebioticsProbioticsSynbioticsPrebioticsalcoholdietgut microbiomegut microbiotahuman studiesprebioticsprobioticssynbiotics

Identifiers

PMID32027044
PMCPMC9291485

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.